Back

P112
Epithelial-to-mesenchymal transition is required for a therapeutic effect of epicardial-derived cells after myocardial infarction

Cardiovascular Research

23 April 2018
Organised by: Logo
Read full article
ESC Journals

Contributors

A M Smits
A M Smits

Author

AMD Vegh
AMD Vegh

Author

T Van Herwaarden
T Van Herwaarden

Author

M J Goumans
M J Goumans

Author

You may be interested in
thumbnail
Congress Presentation
SMAD3 silencing induces Epithelial-to-Mesenchymal Transition (EMT) towards cardiac pericyte progenitors with proangiogenic potential in hiPSC-derived epicardial cells
30 August 2024
thumbnail
Congress Presentation
Evaluation of intrapericardial regenerative therapy in a porcine myocardial infarction model: comparison between free versus microencapsulated CDCs delivery
29 June 2021
thumbnail
Congress Presentation
Systemic administration of hEPSC-derived Trophoblast stem cells for cardiac regeneration
29 August 2025
thumbnail
Congress Presentation
The paradox of the association between epicardial adipose tissue, infarct size and left ventricular remodelling after ST-segment elevation myocardial infarction: a CMR study
27 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources